PCR214 The Value of Technology to Reduce Barriers to Clinical Trial Diversity and Facilitate the Development of Patient-Centric Medicine
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.2147
https://www.valueinhealthjournal.com/article/S1098-3015(22)04352-2/fulltext
Title :
PCR214 The Value of Technology to Reduce Barriers to Clinical Trial Diversity and Facilitate the Development of Patient-Centric Medicine
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)04352-2&doi=10.1016/j.jval.2022.09.2147
First page :
Section Title :
Open access? :
No
Section Order :
11702